Risk factors include vegetarian or vegan diets, age over 50 (reduced gastric acid impairs absorption), proton pump inhibitor use, prior gastric surgery, and Type 1 diabetes
A little on my nose as well
It targets two hormone pathways, GIP and GLP-1, which regulate appetite, digestion, and insulin release
Browse user-created protocols Real protocols from the community that include Glow Blend (GHK-Cu, BPC-157, TB-500) Glow Blend (GHK-Cu, BPC-157, TB-500) Research References It is a preclinical compound Glow Blend (GHK-Cu, BPC-157, TB-500) Glow Blend (GHK-Cu, BPC-157, TB-500) is a preclinical compound Dose range 250-500mcg daily shows wound healing and anti-inflammatory properties n.d
Other possible effects include fatigue or transient increases in heart rate during activity
All rats underwent surgery under anesthesia, obtained by an intraperitoneal injection of xylazine (8 mg/kg) and ketamine (80 mg/kg)